Mesenchymal stromal cell delivery of full-length tumor necrosis factor–related apoptosis-inducing ligand is superior to soluble type for cancer therapy-Reference-Cited by-同舟云学术

Mesenchymal stromal cell delivery of full-length tumor necrosis factor–related apoptosis-inducing ligand is superior to soluble type for cancer therapy

Published:2015-07 Issue:7 Volume:17 Page:885-896
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Yuan ZhengQiang,Kolluri Krishna K.,Sage Elizabeth K.,Gowers Kate H.C.,Janes Sam M.

Funder

Wellcome Trust Senior Fellow in Clinical Science

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference60 articles.

1. Identification and characterization of a new member of the TNF family that induces apoptosis;Wiley;Immunity,1995

2. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family;Pitti;J Biol Chem,1996

3. Selective CDK9 inhibition overcomes TRAIL resistance by concomitant suppression of cFlip and Mcl-1;Lemke;Cell Death Differ,2014

4. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo;Walczak;Nat Med,1999

5. Safety and antitumor activity of recombinant soluble Apo2 ligand;Ashkenazi;J Clin Invest,1999

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma;Cell Reports Medicine;2024-08

2. Auto-loaded TRAIL-exosomes derived from induced neural stem cells for brain cancer therapy;Journal of Controlled Release;2024-08

3. Auto-loaded TRAIL-exosomes derived from induced neural stem cells for brain cancer therapy;2024-05-29

4. Revolutionizing Cancer Treatment: Harnessing the Power of Mesenchymal Stem Cells for Precise Targeted Therapy in the Tumor Microenvironment;Current Topics in Medicinal Chemistry;2024-05-23

5. Lentiviral expression of wild-type LAMA3A restores cell adhesion in airway basal cells from children with epidermolysis bullosa;Molecular Therapy;2024-05